Evidence map›Paper›PMID 41923133›Full record

ArticleJournal of nanobiotechnology2026

Synchronous PET/MR imaging and visualizing penetration of nanomedicine within tumor based on

Sitong Wu, Wenyue Li, Qi Yang, Lele Song, Wenpeng Huang, Zhao Chen, Bixiao Cui, Jie Lu, Yinghua Zou, Yi Hou and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sitong Wu *Department of Radiology, China-Japan Friendship Hospital, Beijing, 100029, China.
Wenyue Li *College of Materials Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Qi Yang *Department of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China.
Lele SongDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China.
Wenpeng HuangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China.
Zhao ChenDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China.
Bixiao CuiDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Jie LuDepartment of Radiology and Nuclear Medicine, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. Imaginglu@hotmail.com.
Yinghua ZouDepartment of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, 100034, China. pkuzouyhua@163.com.
Yi HouCollege of Materials Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China. houyi@iccas.ac.cn.
Lei KangDepartment of Nuclear Medicine, Peking University First Hospital, Beijing, 100034, China. kanglei@bjmu.edu.cn.

Funding

Beijing Nova Program 20240484725National High Level Hospital Clinical Research Funding, Elite Medical Professionals Initiative of China-Japan Friendship Hospital NO.ZRJY2025-QMPY27National Key Research and Development Program of China 2024YFE0113500
6 · The paper itself

Abstract

Magnetic resonance imaging (MRI) and nuclear medicine imaging are widely used for cancer detection due to their high soft tissue resolution and sensitivity. Each modality has inherent limitations; therefore, integrated techniques such as positron emission tomography/magnetic resonance (PET/MR) have been developed. However, achieving simultaneous signal enhancement for both PET and MRI in clinical settings remains challenging. In this study, we employed gallium-68 (

Indexed as

GadoliniumGallium RadioisotopesMagnetic Resonance ImagingNanomedicineNeoplasmsPositron-Emission TomographyAnimalsCell Line, TumorFemaleHumansMiceMice, NudeMultimodal ImagingNanoparticlesTissue DistributionGadoliniumGallium-68Gallium RadioisotopesMagnetic resonance imagingNaGdF4 nanoparticlesPenetrationPositron emission tomographySynchronous multi-modality imaging

Identifiers

PMID41923133
PMCPMC13169577

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.